1,103
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Guizhi Fuling Wan inhibits autophagy of granulosa cells in polycystic ovary syndrome mice via H19/miR-29b-3p

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2210232 | Received 07 Mar 2023, Accepted 28 Apr 2023, Published online: 15 May 2023

References

  • Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):1–8. PubMed PMID: 30033227; PubMed Central PMCID: PMCPMC6939856.
  • Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545–1573. PubMed PMID: 31384717; PubMed Central PMCID: PMCPMC6676075.
  • Aversa A, La Vignera S, Rago R, et al. Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front Endocrinol (Lausanne). 2020;11:516. PubMed PMID: 32849300; PubMed Central PMCID: PMCPMC7431619.
  • Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940.
  • Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28(3):186–198.
  • Palomba S. Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. Hum Reprod. 2021;36(9):2421–2428. PubMed PMID: 34333641; eng.
  • Brabaharan S, Veettil SK, Kaiser JE, et al. Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies. JAMA Netw Open. 2022;5(1):e2143730. PubMed PMID: 35029663; PubMed Central PMCID: PMCPMC8760614.
  • Ge JJ, Wang DJ, Song W, et al. The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis. J Endocrinol Invest. 2022;45(2):261–273.
  • Liu J, Wu DC, Qu LH, et al. The role of mTOR in ovarian neoplasms, polycystic ovary syndrome, and ovarian aging. Clin Anat. 2018;31(6):891–898.
  • Li X, Qi J, Zhu Q, et al. The role of androgen in autophagy of granulosa cells from PCOS. Gynecol Endocrinol. 2019;35(8):669–672.
  • Xu B, Dai W, Liu L, et al. Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K/AKT/mTOR pathway. Endocr J. 2022;69(7):863–875.
  • Chen X, Tang H, Liang Y, et al. Acupuncture regulates the autophagy of ovarian granulosa cells in polycystic ovarian syndrome ovulation disorder by inhibiting the PI3K/AKT/mTOR pathway through LncMEG3. Biomed Pharmacother. 2021;144:112288.
  • Di Fazio P, Rusche FD, Roth S, et al. Long non-coding RNA H19 expression correlates with autophagy process in adrenocortical carcinoma. Cancer Invest. 2022;40(3):254–267.
  • Xu X, Cui L, Zhong W, et al. Autophagy-Associated lncRNAs: promising targets for neurological disease diagnosis and therapy. Neural Plast. 2020;2020:8881687. PubMed PMID: 33029125; PubMed Central PMCID: PMCPMC7528122.
  • Chen Z, Wei H, Zhao X, et al. Metformin treatment alleviates polycystic ovary syndrome by decreasing the expression of MMP-2 and MMP-9 via H19/miR-29b-3p and AKT/mTOR/autophagy signaling pathways. J Cell Physiol. 2019;234(11):19964–19976.
  • Song G, Zhou J, Song R, et al. Long noncoding RNA H19 regulates the therapeutic efficacy of mesenchymal stem cells in rats with severe acute pancreatitis by sponging miR-138-5p and miR-141-3p. Stem Cell Res Ther. 2020;11(1):420. PubMed PMID: 32977843; PubMed Central PMCID: PMCPMC7519546.
  • Chinese Pharmacopoeia Commission. Guizhi Fuling Wan. In: Chinese pharmacopoeia commission. Chinese Pharmacopoeia; Beijing, China: China Medical Science Press. 2020. p. 1439.
  • Liu M, Zhu H, Hu X, et al. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: a protocol for a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020;99(44):e22954. PubMed PMID: 33126363; PubMed Central PMCID: PMCPMC7598780.
  • Liu M, Zhu H, Zhu Y, et al. Guizhi fuling wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821.
  • Zhu Y, Li Y, Liu M, et al. Guizhi Fuling Wan, Chinese herbal medicine, ameliorates insulin sensitivity in PCOS model rats with insulin resistance via remodeling intestinal homeostasis. Front Endocrinol (Lausanne). 2020;11:575. PubMed PMID: 32973686; PubMed Central PMCID: PMCPMC7482315.
  • Panossian A, Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008;118(2):183–212.
  • Balen AH, Rutherford AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ. 2007;335(7621):663–666. PubMed PMID: 17901517; PubMed Central PMCID: PMCPMC1995495.
  • Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014;6(1):104–119. PubMed PMID: 24389146; PubMed Central PMCID: PMCPMC4341818.
  • Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–592.
  • Fan L, Wang C, Zhan P, et al. miR-141-3p is poorly expressed in polycystic ovary syndrome and correlates with glucose and lipid metabolism. Int J Endocrinol. 2021;2021:2022938. PubMed PMID: 34659401; PubMed Central PMCID: PMCPMC8519708.
  • Sang Z, Dong S, Zhang P, et al. miR-214 ameliorates sepsis-induced acute kidney injury via PTEN/AKT/mTOR-regulated autophagy. Mol Med Rep. 2021;24(4):683. PubMed PMID: 34328194; PubMed Central PMCID: PMCPMC8365606.
  • Devis-Jauregui L, Eritja N, Davis ML, et al. Autophagy in the physiological endometrium and cancer. Autophagy. 2021;17(5):1077–1095. PubMed PMID: 32401642; PubMed Central PMCID: PMCPMC8143243.